Ophthalmic Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

CDC: Children Need Vision Care

Millions of infants and children aren't receiving recommended medical care aimed at detecting and preventing disease, including vision screenings.

Eylea Gains New Indication

FDA has approved Eylea (aflibercept) injection for the treatment of diabetic macular edema (DME).

Sun Exposure and Exfoliation Syndrome

Cumulative lifetime outdoor activities may contribute to exfoliation syndrome (XFS).

No Cataract Protection with Vitamin E

Daily supplements of selenium or vitamin E don't seem to protect against the development of age-related cataracts among men.

Vision Loss Post-Spinal Fusion

Though rare, some patients are at higher risk for perioperative visual loss (POVL) after spinal fusion surgery.

Declining Vision and Mortality

Among aging adults, decreasing visual acuity is associated with increased mortality risk.

Risks for Diabetic Macular Edema

Some subpopulations of patients with diabetes carry a higher burden of diabetic macular edema (DME).

Chart: Bacterial Conjunctivitis Treatments

Review this chart on Bacterial Conjunctivitis Treatments for quick information when you need it.


Avedro Resubmits NDA for Eye Disorders

Avedro announced that it has resubmitted its New Drug Application (NDA) to the Food and Drug Administration (FDA) for riboflavin ophthalmic solution/KXL System for the treatment of progressive keratoconus or corneal ectasia following refractive surgery.

Ozurdex Gains General DME Indication

Allergan announced that the Food and Drug Administration (FDA) has approved Ozurdex (dexamethasone intravitreal implant) for the treatment of diabetic macular edema (DME).

Iluvien Implant Gains FDA Approval for DME

Alimera Sciences announced that the Food and Drug Administration (FDA) has approved Iluvien (fluocinolone acetonide intravitreal implant) for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).

Clinical Charts

Make prescribing decisions with our charts and treatment algorithms.

Featured courses from mycme

Pulmonology, Pediatrics, Ophthalmology, and ENTExternal web site

This module reviews all topics on the NCCPA examination blueprint relating to Pulmonology, Ophthalmology, and ...

CME 5.00 Credits

MediBrief: A Yearly Review of Diabetic Macular EdemaExternal web site

PracticeSM from Primary to Specialty Care is a certified, opt-in, educational activity that briefly provides ...

CME 1.00 Credits

Treatment Decision-Making for Age-Related Macular DegenerationExternal web site

The content of this activity is based on a live symposium held at the ASRS ...

CME 1.25 Credits

Sign Up for Free e-newsletters